INVARIANT LLC for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 2166/S. 150, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020, to amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans, and for other purposes; H.R. 2608, the Ensuring Seniors Access to Local Pharmacies Act of 2021; H.R. 2846, the Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021; H.R. 4074 - To expand the availability of supplemental benefits to certain Medicare Advantage enrollees; H.R.3173, the Improving Seniors Timely Access to Care Act of 2021; issues related to Pharmacy Direct and Indirect Remuneration (DIR); policies that impact public programs payments for high cost drugs including gene therapies; proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap and direct negotiation of prescription drug prices; policies that impact Medicare vision, dental, and hearing benefits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Defense DEF
Pharmacy issues related to TRICARE and H.R. 4350 the National Defense Authorization Act (NDAA) for Fiscal Year 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| ANNABELL MCWHERTER STOKES | — |
| KATHRYN WISE | — |
Health Issues HCR
Issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, stand-alone dental plans, and non-discrimination provisions; issues related to the drug and medical device supply chain concerns related to the coronavirus response efforts; issues related to H.R. 19/S. 2164, the Lower Costs, More Cures Act; issues related to the Improving Health Care Affordability Act; issues related to the Build Back Better Act, budget reconciliation legislation; June 24, 2019 Executive Order, "Improving Price and Quality Transparency in American Healthcare to Put Patients First."
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.